Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023433
Filing Date
2017-11-13
Accepted
2017-11-13 07:51:16
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q_2017 3RD QUARTER reta-10q_20170930.htm 10-Q 1365219
2 EX-1.1 ATM AGREEMENT reta-ex11_709.htm EX-1.1 223126
3 EX-5.1 V&E OPINION reta-ex51_978.htm EX-5.1 17647
4 EX-10.1 LEASE AMENDMENT reta-ex101_517.htm EX-10.1 68423
5 EX-31.1 reta-ex311_7.htm EX-31.1 18960
6 EX-31.2 reta-ex312_6.htm EX-31.2 18883
7 EX-32.1 reta-ex321_9.htm EX-32.1 10186
8 EX-32.2 reta-ex322_8.htm EX-32.2 10176
9 GRAPHIC g201711102054032745692.jpg GRAPHIC 18021
10 GRAPHIC g201711102053564055553.jpg GRAPHIC 4837
11 GRAPHIC g201711102053563815553.jpg GRAPHIC 13096
  Complete submission text file 0001564590-17-023433.txt   3916354

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT reta-20170930.xml EX-101.INS 481590
13 XBRL TAXONOMY EXTENSION SCHEMA reta-20170930.xsd EX-101.SCH 27741
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20170930_cal.xml EX-101.CAL 32330
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20170930_def.xml EX-101.DEF 97286
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20170930_lab.xml EX-101.LAB 231445
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20170930_pre.xml EX-101.PRE 176448
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 171193171
SIC: 2834 Pharmaceutical Preparations